# Hyperpolarized MRI for GIST on Imatinib

> **NCT07724626** · — · NOT_YET_RECRUITING · sponsor: **Chang Gung Memorial Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Imatinib Therapy Response
- Gastrointestinal Stromal Tumor (GIST)

## Interventions

- **DRUG:** Hyperpolarized 13C-MRI

## Key facts

- **NCT ID:** NCT07724626
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01-01
- **Primary completion:** 2028-07-31
- **Final completion:** 2028-10-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07724626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07724626, "Hyperpolarized MRI for GIST on Imatinib". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07724626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*